Meiji Yasuda Asset Management CO Ltd. Exact Sciences Corp Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.56 Billion
- Q4 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 5,774 shares of EXAS stock, worth $255,499. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,774
Previous 5,774
-0.0%
Holding current value
$255,499
Previous $393,000
17.56%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
667Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$776 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$753 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$534 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$276 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$255 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.83B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...